|
 |
Kaubanduslikud nimed erinevates maades |
|
|
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
|
|
Acetaflur |
Mehhiko |
|
Asoleudox |
Mehhiko |
|
Beneflur |
Hispaania, Mehhiko |
|
Fludabin |
Maroko |
|
Fludacel |
India, Maroko |
|
Fludakebir |
Maroko |
|
Fludalym |
Türgi |
|
Fludara |
Ameerika ühendriigid, Austria, Belgia, Egiptus, Holland, Iirimaa, India, Iraan, Itaalia, Kolumbia, Luksemburg, Malaisia, Poola, Portugal, Prantsusmaa, Rootsi, Rumeenia, Saksamaa, Saudi Araabia, Soome, Suurbritannia, Sveits, Taani, Tšiili, Ungari, uus-Meremaa, Venetsueela |
|
Fludarabin |
Island, Itaalia, Norra, Rootsi, Sveits |
|
Fludarabina |
Argentiina, Hispaania, Kolumbia, Maroko, Rumeenia |
|
Fludarabine |
Ameerika ühendriigid, Belgia, Iraan, Kanada, Norra, Sveits, uus-Meremaa |
|
Fludarin |
India |
|
Fludarosa |
Argentiina |
|
Forclina |
Maroko |
|
Ludabina |
Kolumbia, Tšiili |
|
Mepredin |
Maroko |
|
Naprobin |
India |
|
Neoflubin |
Iraan |
|
|
 |
 |
Viited : Fludarabine phosphate |
|
|
tüüp |
avaldamine |
| 3 |
ajaleht |
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212. |
| 81 |
ajaleht |
Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678. |
| 84 |
ajaleht |
Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499. |
| 99 |
ajaleht |
Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090. |
| 169 |
ajaleht |
Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363. |
| 182 |
ajaleht |
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60. |
| 244 |
ajaleht |
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913. |
| 249 |
ajaleht |
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045. |
| 307 |
ajaleht |
Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799. |
| 492 |
ajaleht |
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189. |
| 905 |
ajaleht |
Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017. |
| 1410 |
ajaleht |
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145. |
| 1423 |
ajaleht |
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518. |
| 3306 |
ajaleht |
Trittler R.
New stability studies for fludarabine according to the European Pharmacopoeia 7.0
EJOP 2012 ; 6, 1: 1-2. |
| 3595 |
Labor |
Aciclovir - Summary of Product Characteristics
Hospira 2009 |
| 3604 |
Labor |
Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2012 |
| 3637 |
Labor |
Methotrexate (Methotrexate solution for injection®) - Summary of Product Characteristics
Hameln Pharmaceuticals 2014 |
| 3644 |
Labor |
Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010 |
| 3670 |
ajaleht |
Sewell G, Massimini M.
Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system.
EJOP 2014 ; 8, 3: 26-30. |
| 3838 |
Labor |
Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007 |
| 4398 |
ajaleht |
Smith E. K., Shergold J.A., McWhinney B.C.
Compatibility of intravenous busulfan with BBraun giving sets, fludarabine and Posiflush.
J Pharm Pract and Res 2020 |
| 4964 |
Labor |
GLUCONATE DE CALCIUM 10 % B.BRAUN, solution pour perfusion - Résumé des caractéristiques du produit.
B BRAUN MELSUNGEN AG 2019 |
|
|
